What is the price target for CVNA stock?
32 analysts have analysed CVNA and the average price target is 429.34 USD. This implies a price increase of 40.32% is expected in the next year compared to the current price of 305.97.
NYSE:CVNA • US1468691027
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARVANA CO (CVNA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | Needham | Reiterate | Buy -> Buy |
| 2026-02-20 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-20 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-19 | DA Davidson | Maintains | Neutral -> Neutral |
| 2026-02-19 | BTIG | Maintains | Buy -> Buy |
| 2026-02-19 | Deutsche Bank | Maintains | Buy -> Buy |
| 2026-02-19 | Needham | Reiterate | Buy -> Buy |
| 2026-02-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-19 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2026-02-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-19 | B of A Securities | Maintains | Buy -> Buy |
| 2026-01-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-21 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-15 | BTIG | Maintains | Buy -> Buy |
| 2026-01-14 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-23 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-12-19 | BTIG | Reiterate | Buy -> Buy |
| 2025-12-19 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-12-15 | Argus Research | Initiate | Buy |
| 2025-12-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-11 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.771B -20.82% | 13.673B 26.94% | 20.322B 48.63% | 27.315B 34.41% | 33.714B 23.43% | 40.161B 19.12% | 48.445B 20.63% | 59.037B 21.86% | 76.518B 29.61% | 91.637B 19.76% | 109.771B 19.79% | |
| EBITDA YoY % growth | 288M 123.19% | 1.295B 349.65% | 2.156B 66.49% | 2.954B 37.01% | 3.838B 29.93% | 4.75B 23.76% | 5.576B 17.39% | 7.337B 31.58% | 9.235B 25.87% | 11.256B 21.88% | 13.716B 21.86% | |
| EBIT YoY % growth | -64M 95.74% | 990M 1,646.88% | 1.881B 90.00% | 2.614B 38.97% | 3.464B 32.52% | 4.341B 25.32% | 5.155B 18.75% | 6.11B 18.53% | 8.732B 42.91% | 15.81B 81.06% | 18.666B 18.06% | |
| Operating Margin | -0.59% | 7.24% | 9.26% | 9.57% | 10.27% | 10.81% | 10.64% | 10.35% | 11.41% | 17.25% | 17.00% | |
| EPS YoY % growth | -3.52 53.19% | 1.57 144.60% | 4.88 210.83% | 7.13 46.14% | 10.00 40.18% | 12.69 26.91% | 16.07 26.62% | 11.53 -28.25% | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.45 -4.02% | 1.88 47.05% | 2.18 111.97% | 1.77 67.03% | 2.27 56.95% | 3.05 62.30% | 3.33 52.30% | 2.85 61.02% |
| Revenue Q2Q % growth | 6.131B 44.87% | 6.671B 37.83% | 7.137B 26.39% | 6.683B 19.28% | 7.817B 27.50% | 8.53B 27.87% | 9.318B 30.56% | 8.883B 32.92% |
| EBITDA Q2Q % growth | 658.09M 40.92% | 766.45M 17.55% | 816.31M 7.69% | 716.74M 2.54% | 855.85M 30.05% | 1.026B 33.86% | 1.079B 32.18% | 950.71M 32.64% |
| EBIT Q2Q % growth | 563.54M 43.03% | 679.44M 32.96% | 732.35M 32.67% | 612.68M 44.50% | 741.13M 31.51% | 946.97M 39.38% | 1.022B 39.55% | 925.24M 51.02% |
All data in USD
32 analysts have analysed CVNA and the average price target is 429.34 USD. This implies a price increase of 40.32% is expected in the next year compared to the current price of 305.97.
CARVANA CO (CVNA) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of CARVANA CO (CVNA) is 1.45 USD and the consensus revenue estimate is 6.13B USD.
The consensus rating for CARVANA CO (CVNA) is 80.625 / 100 . This indicates that analysts generally have a positive outlook on the stock.